Doxorubicin versus doxorubicin and cisplatin in endometrial carcinoma: definitive results of a randomised study (55872) by the EORTC Gynaecological Cancer Group. - Aapro,M.S.; van Wijk,F.H.; Bolis,G.; Chevallier,B.; van der Burg,M.EL.; Poveda,A.; de Oliveira,C.F.; Tumolo,S.; Scotto di Palumbo,V.; Piccart,M.; Franchi,M.; Zanaboni,F.; et al. (Ann Oncol, 2003)